VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
LRCX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
LRCXLam Research Corporation
$263.94$330.1B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLRCXFinancials

Lam Research Corporation (LRCX) Income Statement

30Y historyFree accessUpdated daily

Revenue accelerated 30% year-over-year to $6.7B in 2026Q4, with gross margin expanding to 51.7% and operating margin reaching 37.4%, driving EPS growth of 148% from $0.73 to $1.81 over ten quarters.

Income StatementBalance SheetCash FlowRatios

LRCX Income Statement

Annual statement

LRCX Income Statement

Lam Research Corporation (LRCX) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricJun'26Jun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97
Sales/Revenue23.23B18.44B14.91B17.43B17.23B14.63B10.04B9.65B11.08B8.01B5.89B5.26B4.61B3.6B2.67B3.24B2.13B1.12B2.47B2.57B1.64B1.5B935.95M755.23M943.11M1.52B1.23B647.96M1.05B1B
Revenue Growth %26.02%23.68%-14.47%1.16%17.78%45.61%4.05%-12.85%38.23%36.15%11.91%14.15%28.02%35.03%-17.68%51.74%91.21%-54.91%-3.57%56.29%9.3%60.53%23.93%-19.92%-37.94%23.48%89.95%-38.44%5.01%-23.47%
Cost of Goods Sold11.51B9.46B7.85B9.65B9.36B7.82B5.44B5.3B5.91B4.41B3.27B2.97B2.6B2.2B1.58B1.74B1.16B727.21M1.3B1.26B815.16M738.99M504.9M451.4M677.02M862.32M691.16M414.59M646.51M689.46M
COGS % of Revenue49.53%51.3%52.68%55.38%54.31%53.47%54.12%54.85%53.37%55.03%55.51%56.57%56.43%61.01%59.32%53.76%54.54%65.17%52.59%49.15%49.64%49.19%53.95%59.77%71.79%56.74%56.16%63.98%61.42%68.78%
Gross Profit11.73B8.98B7.05B7.78B7.87B6.81B4.61B4.36B5.17B3.6B2.62B2.28B2.01B1.4B1.08B1.5B969.93M388.73M1.17B1.31B827.01M763.46M431.05M303.83M266.09M657.47M539.61M233.36M406.07M312.94M
Gross Margin %50.47%48.7%47.32%44.63%45.69%46.53%45.88%45.15%46.63%44.97%44.49%43.43%43.57%38.99%40.68%46.24%45.46%34.83%47.41%50.85%50.36%50.81%46.05%40.23%28.21%43.26%43.84%36.02%38.58%31.22%
Gross Profit Growth %30.59%27.31%-9.31%-1.21%15.67%47.66%5.74%-15.62%43.34%37.59%14.65%13.79%43.08%29.43%-27.6%54.36%149.51%-66.87%-10.09%57.8%8.32%77.12%41.87%14.18%-59.53%21.84%131.23%-42.53%29.76%-52.27%
Operating Expenses3.53B3.08B2.79B2.6B2.49B2.32B1.93B1.89B1.95B1.7B1.54B1.5B1.33B1.28B846.34M692.95M544.52M669.98M663.98M526.39M422.24M375.32M324.87M309.21M385.93M470.94M309.76M346.56M587M376.73M
OpEx % of Revenue15.17%16.7%18.71%14.93%14.45%15.88%19.26%19.62%17.62%21.23%26.24%28.45%28.86%35.7%31.76%21.4%25.52%60.04%26.83%20.51%25.71%24.98%34.71%40.94%40.92%30.99%25.17%53.49%55.77%37.58%
Selling, General & Admin1.15B981.7M868.25M832.75M885.74M829.88M682.48M702.41M762.22M667.49M630.95M591.61M613.34M599.49M400.05M308.07M240.94M237.71M287.99M241.05M192.24M165.83M146.06M132.82M161.86M218.92M161.35M145.7M201.9M197.09M
SG&A % of Revenue4.95%5.33%5.83%4.78%5.14%5.67%6.79%7.28%6.88%8.33%10.72%11.25%13.31%16.66%15.01%9.52%11.29%21.3%11.64%9.39%11.71%11.04%15.61%17.59%17.16%14.4%13.11%22.49%19.18%19.66%
Research & Development2.38B2.1B1.9B1.73B1.6B1.49B1.25B1.19B1.19B1.03B913.71M825.24M716.47M683.69M444.56M373.29M320.86M288.27M323.76M285.35M228.89M195.29M170.48M160.49M179.22M227.25M176.9M142.5M206.46M170.62M
R&D % of Revenue10.23%11.37%12.76%9.91%9.31%10.21%12.47%12.34%10.74%12.9%15.52%15.69%15.55%19%16.68%11.53%15.04%25.83%13.08%11.12%13.94%13%18.21%21.25%19%14.95%14.37%21.99%19.61%17.02%
Other Operating Expenses0018.19M42.15M000000079.44M01.81M1.73M11.58M-17.28M144M52.22M01.11M14.2M8.33M15.9M44.85M24.77M-28.48M58.37M178.64M9.02M
Operating Income8.2B5.9B4.26B5.17B5.38B4.48B2.67B2.46B3.21B1.9B1.07B788.04M677.67M118.07M237.73M804.28M425.41M-281.24M509.43M778.66M404.77M391M106.18M-5.38M-119.84M186.53M229.84M-113.2M-180.92M-63.79M
Operating Margin %35.29%32.01%28.61%29.7%31.24%30.64%26.62%25.53%29.01%23.74%18.25%14.98%14.71%3.28%8.92%24.84%19.94%-25.2%20.58%30.34%24.65%26.02%11.34%-0.71%-12.71%12.27%18.67%-17.47%-17.19%-6.36%
Operating Income Growth %38.96%38.39%-17.6%-3.85%20.08%67.63%8.48%-23.3%68.93%77.07%36.32%16.29%473.95%-50.33%-70.44%89.06%251.26%-155.21%-34.58%92.37%3.52%268.24%2071.77%95.51%-164.25%-18.84%303.04%37.43%-183.63%-132.53%
EBITDA8.64B6.29B4.62B5.52B5.72B4.79B2.94B2.77B3.54B2.21B1.37B1.07B969.92M422.19M338.56M879.04M496.81M-208.83M564.13M816.1M426.77M416.52M141.55M39.58M-55.5M245.26M275.86M-62.28M-118.66M-10.68M
EBITDA Margin %37.19%34.1%31.02%31.66%33.18%32.74%29.29%28.74%31.96%27.57%23.2%20.27%21.05%11.73%12.7%27.15%23.28%-18.71%22.79%31.8%25.99%27.72%15.12%5.24%-5.88%16.14%22.41%-9.61%-11.27%-1.07%
EBITDA Growth %37.44%35.98%-16.2%-3.47%19.34%62.77%6.07%-21.63%60.24%61.8%28.08%9.9%129.74%24.7%-61.49%76.94%337.91%-137.02%-30.87%91.23%2.46%194.25%257.62%171.32%-122.63%-11.09%542.95%47.52%-1011.04%-104.62%
D&A (Non-Cash Add-back)441.53M386.28M359.7M342.43M333.74M307.15M268.52M309.28M326.39M306.9M291.03M277.92M292.25M304.12M100.83M74.76M71.4M72.42M54.7M37.44M22M25.52M35.37M44.97M64.34M58.73M46.02M50.92M62.27M53.11M
EBIT8.26B5.96B4.55B5.3B5.38B4.58B2.75B2.56B3.25B1.93B1.09B814.53M785.05M127.07M243.38M806.26M431.13M-256.6M589.65M865.54M440.83M400.54M114.51M10.52M-74.99M215.29M199.11M-54.83M29.65M-54.77M
Net Interest Income053.13M66.7M-47.48M-169.55M-188.91M-92.01M-18.49M-11.57M-59.88M-105.26M-54.41M-49.15M-45.67M-26.82M10.19M7.6M17.79M38.52M53.85M37.14M16.12M00000000
Interest Income0231.33M251.94M138.98M15.21M19.69M85.43M98.77M85.81M57.86M29.51M19.27M12.54M14.74M12.14M15.57M8.6M24.28M51.19M71.67M38.19M17.54M00000000
Interest Expense0178.2M185.24M186.46M184.76M208.6M177.44M117.26M97.39M117.73M134.77M73.68M61.69M60.41M38.96M5.38M994K6.5M12.67M17.82M1.04M1.41M00000000
Other Income/Expense62.68M57.16M96.31M-65.65M-188.71M-111.22M-98.82M-18.16M-61.51M-90.46M-114.14M-47.19M45.69M-51.41M-33.31M-3.41M4.73M18.15M67.55M69.06M35.02M8.12M4.47M-10.26M-8.16M15.1M6.97M288K1.8M-1.49M
Pretax Income8.26B5.96B4.36B5.11B5.19B4.37B2.57B2.45B3.15B1.81B960.12M740.85M723.36M66.66M204.42M800.88M430.14M-263.09M576.98M847.72M441.29M399.12M110.65M-15.64M-128M201.63M236.81M-112.91M-179.13M-65.28M
Pretax Margin %35.56%32.32%29.25%29.32%30.15%29.88%25.64%25.34%28.45%22.61%16.31%14.09%15.7%1.85%7.67%24.74%20.16%-23.58%23.31%33.03%26.87%26.56%11.82%-2.07%-13.57%13.27%19.24%-17.43%-17.02%-6.51%
Income Tax997.08M599.91M532.45M598.28M587.83M462.35M323.23M255.14M771.11M113.91M46.07M85.27M91.07M-47.22M35.7M77.13M83.47M39.05M137.63M161.91M104.58M99.78M27.66M-7.91M-37.94M60.5M32.06M0-34.53M-31.64M
Effective Tax Rate %12.07%10.07%12.21%11.71%11.32%10.58%12.55%10.43%24.47%6.29%4.8%11.51%12.59%-70.84%17.46%9.63%19.41%-14.84%23.85%19.1%23.7%25%25%50.53%29.64%30%13.54%0%19.27%48.48%
Net Income7.27B5.36B3.83B4.51B4.61B3.91B2.25B2.19B2.38B1.7B914.05M655.58M632.29M113.88M168.72M723.75M346.67M-302.15M439.35M685.82M335.75M299.34M82.99M-7.74M-90.05M52.11M204.76M-112.91M-144.6M-33.63M
Net Margin %31.27%29.06%25.68%25.89%26.73%26.72%22.42%22.7%21.49%21.19%15.53%12.47%13.72%3.16%6.33%22.35%16.25%-27.08%17.75%26.72%20.45%19.92%8.87%-1.02%-9.55%3.43%16.64%-17.43%-13.74%-3.36%
Net Income Growth %35.59%39.98%-15.14%-2.05%17.83%73.57%2.75%-7.95%40.22%85.74%39.43%3.68%455.23%-32.51%-76.69%108.77%214.73%-168.77%-35.94%104.26%12.16%260.7%1172.33%91.41%-272.82%-74.55%281.34%21.91%-329.92%-123.05%
Net Income (Continuing)7.27B5.36B3.83B4.51B4.61B3.91B2.25B2.19B2.38B1.7B914.05M655.58M632.29M113.88M168.72M723.75M346.67M-302.15M439.35M685.82M335.21M299.34M82.99M-7.74M-90.05M141.14M204.76M-112.91M-144.6M-33.63M
Discontinued Operations000000000000000000000000000000
Minority Interest0000000000000000005.35M00000000000
EPS (Diluted)5.764.152.903.323.272.691.511.371.320.920.520.370.360.070.140.580.27-0.240.350.490.230.210.05-0.01-0.070.040.15-0.10-0.13-0.04
EPS Growth %38.8%43.1%-12.65%1.53%21.56%78.15%10.22%3.79%43.48%76.92%40.54%2.78%445.45%-52.86%-75.86%114.81%212.5%-168.57%-28.57%113.04%9.52%288.89%-91.41%-282.05%-74%253.53%24.85%-254.22%-128.23%
EPS (Basic)5.794.172.913.333.292.721.561.441.471.050.580.410.380.070.140.590.27-0.240.350.490.240.220.06-0.01-0.070.040.17-0.10-0.13-0.04
Diluted Shares Outstanding1.26B1.29B1.32B1.36B1.41B1.45B1.49B1.6B1.81B1.84B1.75B1.77B1.75B1.73B1.25B1.25B1.28B1.26B1.27B1.42B1.44B1.42B1.54B1.26B1.26B1.32B1.43B1.15B1.14B918M
Basic Shares Outstanding1.26B1.29B1.31B1.35B1.4B1.44B1.45B1.52B1.81B1.62B1.59B1.6B1.65B1.69B1.24B1.24B1.27B1.26B1.25B1.39B1.39B1.38B1.41B1.26B1.26B1.24B1.21B1.15B1.14B918M
Dividend Payout Ratio17.49%21.45%26.62%20.13%17.7%18.6%29.17%30.95%12.92%14.34%20.83%17.7%------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

China revenue concentration and EPS miss

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

AI-Driven Revenue Acceleration

Revenue grew 30% year-over-year in 2026Q4 to $6.7B, accelerating from 20.7% in 2024Q4, driven by AI-related wafer fab equipment demand, according to recent financial statements.

The sequential revenue progression from $3.8B in 2024Q3 to $6.7B in 2026Q4 shows a clear acceleration, with growth rates climbing from negative to 30% over ten quarters. This suggests that AI-driven demand for advanced memory and logic nodes is more than offsetting cyclicality, as evidenced by the consistent quarter-over-quarter increases. The durability of this growth appears tied to the technology treadmill in 3D NAND and GAA architectures, which may sustain demand even if broader semiconductor capex softens.

Gross Margin Expansion on Mix

Gross margin expanded from 47.5% in 2024Q3 to 51.7% in 2026Q4, a 420 basis point improvement, as reported in the income statement data, indicating favorable product mix and pricing power.

The gross margin trajectory shows consistent improvement, with the most recent quarter hitting 51.7%, above the peer average of around 50%. This expansion likely reflects a shift toward more complex etch and deposition tools, which command premium pricing, and possibly a higher mix of service revenue. However, the sustainability of this margin level may be challenged by potential under-absorption during any demand downturn, as seen in historical cycles.

Operating Leverage Driving Margin Upside

Operating income grew from $1.1B in 2024Q3 to $2.5B in 2026Q4, with operating margin expanding from 27.9% to 37.4%, as per the income statement, demonstrating significant operating leverage.

The operating margin expansion of nearly 950 basis points over the period outpaced gross margin gains, indicating that SG&A and R&D costs are scaling slower than revenue. R&D as a percentage of revenue declined from 13.5% in 2024Q3 to 9.6% in 2026Q4, while SG&A similarly dropped, suggesting efficient cost control despite increased absolute spending. This leverage appears structural, driven by the high fixed-cost nature of the business, and may continue if revenue growth persists.

EPS Growth Outpacing Revenue

Diluted EPS surged from $0.73 in 2024Q3 to $1.81 in 2026Q4, a 148% increase, while revenue grew 76% over the same period, according to the income statement data, indicating margin expansion and buybacks.

The EPS growth rate of 34.1% in 2026Q4 exceeds revenue growth of 30%, reflecting margin expansion and the impact of share repurchases. However, the recent EPS miss of $0.36 versus consensus suggests that despite record results, expectations were even higher, possibly due to product mix or elevated expenses. The quality of earnings appears solid, with SBC as a percentage of revenue declining from 2.0% to 1.6%, indicating limited dilution.

R&D and SG&A Efficiency

R&D and SG&A combined grew from $712M in 2024Q3 to $965M in 2026Q4, but as a percentage of revenue they fell from 18.8% to 14.4%, as per the income statement, showing disciplined expense management.

The absolute increase in R&D and SG&A reflects investment in next-generation technologies, but the declining percentage of revenue indicates that the company is leveraging its cost base effectively. R&D intensity remains high, which is critical for maintaining the moat in HAR etch, but the efficiency gains suggest that management is balancing innovation with profitability. Investors should monitor whether this efficiency can be maintained as the company scales into new markets.

China Concentration and EPS Miss

Despite record revenue, EPS of $1.82 missed consensus by $0.36, and China concentration remains elevated, as per recent filings, raising concerns about sustainability and geopolitical risk.

The EPS miss, despite record operational performance, may indicate that the market had priced in even more aggressive upside, or that there are hidden margin pressures from product mix or rising costs. The escalating concentration of revenue from China, which has historically exceeded 30-40%, poses a significant risk if export controls tighten or if customers digest inventory. The maintained guidance suggests management confidence, but the wide revenue range of $8.1B +/- $400M implies elevated uncertainty, warranting close monitoring of order trends and customer acceptance.

LRCX — Frequently Asked Questions

Quick answers to the most common questions about buying LRCX stock.

What was Lam Research Corporation's (LRCX) revenue in 2026?

For fiscal year 2026, Lam Research Corporation (LRCX) reported total revenue of $23.23B. This represents a 2217.7% increase compared to $1.00B in 1997.

Is Lam Research Corporation (LRCX) profitable?

Lam Research Corporation (LRCX) is profitable, generating $7.27B in net income for the fiscal year ending 2026 with a net profit margin of 31.3%.

What is Lam Research Corporation's operating profit margin?

Lam Research Corporation (LRCX) reported an operating income of $8.20B, resulting in an operating profit margin of 35.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Lam Research Corporation's gross profit and gross margin?

Lam Research Corporation (LRCX) generated $11.73B in gross profit for the year, representing a gross profit margin of 50.5%. This demonstrates the company's core pricing power and production efficiency.